Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
Other Sizes |
|
Purity: ≥98%
Dizocilpine (MK-801), is a novel, potent, selective and non-competitive NMDA ( N-Methyl-D-aspartate) receptor antagonist with Kd of 37.2 nM in rat brain membranes. (+)-MK-801 blocks NMDA receptors in a use- and voltage-dependent manner, since the channel must open for the drug to bind inside it. The drug acts as a potent anti-convulsant and likely has dissociative anesthetic properties, but it is not used clinically for this purpose due to the discovery of brain lesions, called Olney's lesions in test rats.
ln Vitro |
Dizocilpine (MK-801) gradually reduces the current that is brought on by NMDA. Even after applying Dizocilpine for an extended period of time in the presence of NMDA, Mg2+ (10 mM) stops Dizocilpine from inhibiting the N-Me-D-Asp-induced current. Dizocilpine inhibits single-channel activity in outside-out patches that is triggered by NMDA[3]. When microglia are activated by LPS, BV-2 cells express more Cox-2 protein, and dizocilpine (MK-801; <500 μM) blocks this process. With an EC50 of 400 μM in BV-2 cells, dizocilpine (<500 μM) decreases microglial TNF-α production[4].
|
||
---|---|---|---|
ln Vivo |
Before each METH injection, mice receive a 1 mg/kg dose of dizocilpine (MK 801), which reduces the amount of DA depletion in the striatum by 55%. Additionally, METH's effects on microglial activation in the mouse striatal membrane are lessened by dizocilpine (MK 801) (1 mg/kg)[4]. ) before two reactivation sessions in the home cage exhibits no suppression on subsequent cocaine-primed reinstatement[5]. Dizocilpine ((+)-MK 801) (0.05, 0.2 mg/kg, ip) attenuates subsequent cocaine-primed reinstatement without disruption in rats.
|
||
Animal Protocol |
|
||
References |
[1]. Wong EH, et al. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8.
[2]. Vardhan Reddy KH, et al. Convergent Strategy to Dizocilpine MK-801 and Derivatives. J Org Chem. 2018 Apr 6;83(7):4264-4269. [3]. Huettner JE, et al. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1307-11. [4]. Thomas DM, et al. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 2005 Jul 19;1050(1-2):190-8. [5]. Brown TE, et al. The NMDA antagonist MK-801 disrupts reconsolidation of a cocaine-associated memory for conditioned place preference but not for self-administration in rats. Learn Mem. 2008 Dec 2;15(12):857-65. |
Molecular Formula |
C16H15N
|
---|---|
Molecular Weight |
221.303
|
Exact Mass |
221.1204
|
CAS # |
77086-21-6
|
Related CAS # |
Dizocilpine maleate;77086-22-7;(-)-Dizocilpine maleate;121917-57-5
|
SMILES |
C[C@]1(N2)C3=CC=CC=C3CC2C4=CC=CC=C14
|
InChi Key |
LBOJYSIDWZQNJS-LYKKTTPLSA-N
|
InChi Code |
InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15?,16-/m0/s1
|
Chemical Name |
(5S)-5-methyl-10,11-dihydro-5H-5,10-epiminodibenzo[a,d][7]annulene
|
Synonyms |
Dizocilpine MK801 MK 801 MK-801 MK 801 Maleate Related CAS#
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
---|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.5188 mL | 22.5938 mL | 45.1875 mL | |
5 mM | 0.9038 mL | 4.5188 mL | 9.0375 mL | |
10 mM | 0.4519 mL | 2.2594 mL | 4.5188 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.